0 Comments
0 Shares
1482 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
- Please log in to like, share and comment!
- Inflammatory Bowel Disease Treatment Market to Witness Significant GrowthSWOT Analysis Strength: Inflammatory bowel disease market comprises various treatment options such as aminosalicylates, corticosteroids and immunosuppressant drugs which helps in managing the symptoms. Also, the increasing research and development activities by major manufacturers are focusing on developing novel biologics and biosimilars which is likely to drive the market growth over the...0 Comments 0 Shares 1246 Views 0 Reviews
- Short Bowel Syndrome Arises When A Portion Of The Small Intestine Is Either Removed Surgically Or DamagedThe most common cause of these Syndrome is surgical intervention. It may occur as a result of bowel resection due to conditions such as Crohn's disease, intestinal tumors, mesenteric ischemia, or traumatic injury. Additionally, congenital defects or diseases like volvulus or gastroschisis can also lead to a short bowel. The severity of Short Bowel Syndrome largely depends on the length of the...0 Comments 0 Shares 1462 Views 0 Reviews
- Short Bowel Syndrome In Children Diagnosis And CareShort Bowel Syndrome (SBS) is a complex medical condition that can affect children, typically resulting from surgical removal or congenital defects of a significant portion of the small intestine. The limited absorptive capacity of the remaining intestine can lead to malabsorption of nutrients, fluid imbalances, and other complications. Timely diagnosis and comprehensive care are crucial in...0 Comments 0 Shares 1496 Views 0 Reviews
- Short Bowel Syndrome Market Competitive Landscape And Forecast 2022-2028The Short Bowel Syndrome Market was characterized by intense competition and significant research and development activities. Key pharmaceutical companies and biotech firms were striving to gain a competitive edge in this niche market segment. Some of the prominent players in the SBS market included Shire (a Takeda company), Zealand Pharma, OxThera, and Emmaus Life Sciences. These companies...0 Comments 0 Shares 1814 Views 0 Reviews